April 18, 2018 / 12:10 AM / in a month

Drugmaker Sellas discloses N.Y. federal opioid probe into doctors

Sellas Life Sciences Group Inc, which last year resolved a U.S. probe into allegations the drugmaker paid kickbacks to doctors to prescribe opioids, says federal prosecutors in Manhattan have issued it a subpoena seeking records related to specific physicians.

Sellas, formerly known as Galena Biopharma Inc, previously marketed the fentanyl-based pain medication Abstral. The company disclosed the subpoena in a filing with the U.S. Securities and Exchange Commission on Friday.

To read the full story on Westlaw Practitioner Insights, click here: bit.ly/2EUF1ar

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below